Why Protocol-Ready Doesn’t Mean Trial-Ready in Ovarian Cancer Clinical Trials
Roughly 70 to 80% of ovarian cancer cases are diagnosed at an advanced stage,1 where treatment options are limited and eligibility criteria for clinical trial participation become more difficult to…